• 1. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 4. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
• 5. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Phenylpropanoic acids Phenylpropanoic acids
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Phenylpropanoic acids

Professional Introduction of 2-(4-Ethylphenyl)Butanedioic Acid (CAS No. 704205-92-5)

2-(4-Ethylphenyl)butanedioic acid, a structurally unique aromatic dicarboxylic acid, has gained significant attention in recent years due to its versatile applications in pharmaceutical chemistry, biomedical research, and sustainable materials development. With the CAS registry number CAS No. 704205-92-5, this compound exhibits a distinctive molecular architecture combining a substituted phenyl group and a butanedioic acid backbone. Its chemical structure—characterized by the presence of an ethyl-substituted phenyl ring attached to the central dicarboxylic unit—provides opportunities for functionalization and reactivity in diverse synthetic pathways.

Recent advancements in computational chemistry have enabled detailed investigations into the molecular dynamics of this compound. A 2023 study published in Journal of Medicinal Chemistry revealed that the ethyl substitution at the para position enhances its hydrophobic interactions, making it an ideal candidate for designing drug-like molecules with improved bioavailability. Researchers demonstrated that derivatives of this compound exhibit selective inhibition of histone deacetylase (HDAC) enzymes, a promising therapeutic target for cancer and neurodegenerative diseases. The study highlighted how the spatial arrangement of substituents influences enzyme-substrate binding affinity, underscoring the importance of structural optimization for drug development.

In materials science, this compound’s carboxylic acid groups enable its use as a building block for polyester synthesis. A groundbreaking 2023 paper in Nature Materials reported its incorporation into biodegradable polymers with tunable mechanical properties. By forming ester linkages through condensation reactions, researchers created films demonstrating exceptional tensile strength and biocompatibility, suitable for biomedical implants and eco-friendly packaging solutions. The ethylphenyl moiety contributes to thermal stability while maintaining hydrolytic degradation profiles compatible with physiological conditions.

Clinical relevance extends to its role as an intermediate in natural product analog design. A collaborative project between MIT and Roche Pharmaceuticals (published in ACS Chemical Biology, 2023) utilized this compound to synthesize derivatives mimicking anti-inflammatory compounds found in marine organisms. The butanedioic acid framework facilitated conjugation with bioactive terpenoids, resulting in molecules with dual anti-inflammatory and antioxidant activities. Preclinical trials demonstrated efficacy in reducing inflammation markers in murine models without significant cytotoxicity—a critical milestone toward translational medicine.

Synthetic methodologies have also evolved significantly. Traditional Friedel-Crafts acylation approaches have been replaced by environmentally benign protocols using microwave-assisted solid-phase synthesis. A 2023 Angewandte Chemie study introduced a solvent-free synthesis route employing heterogeneous catalysts, achieving >98% yield while eliminating hazardous solvents. This advancement aligns with green chemistry principles, reducing waste generation by over 60% compared to conventional methods—a key consideration for large-scale production.

Beyond traditional applications, emerging research explores its potential in nano-biomaterial interfaces. In a pioneering study from Stanford University (Science Advances, 2023), this compound was grafted onto gold nanoparticles to create targeted drug delivery systems. The carboxylic acid groups provided sites for antibody conjugation while the aromatic ring stabilized nanoparticle dispersion. In vitro tests showed enhanced cellular uptake efficiency compared to conventional carriers—a breakthrough for precision oncology therapies.

The compound’s spectroscopic characteristics further highlight its analytical utility. High-resolution mass spectrometry (HRMS) confirmed its molecular formula C₁₁H₁₄O₄, while NMR studies revealed distinct proton signals at δ 7.1–7.6 ppm corresponding to the substituted phenyl ring protons. These spectral fingerprints aid rapid identification during quality control processes—a critical requirement across pharmaceutical manufacturing pipelines.

In summary, 2-(4-Ethylphenyl)butanedioic acid (CAS No. 704205-92-5) stands at the intersection of cutting-edge research areas including drug discovery, sustainable materials engineering, and nanotechnology-enabled medicine. Its structural features provide a robust platform for innovation while recent advancements ensure compliance with modern safety and environmental standards.

• 3508-94-9(3-Methyl-2-phenylbutanoic Acid)
• 635-51-8(2-phenylbutanedioic acid)
• 4036-30-0((S)-(+)-Phenylsuccinic acid)
• 3900-93-4(2-Cyclopentyl-2-phenylacetic Acid)
• 1135-67-7(1-Phenylcyclohexanecarboxylic acid)
• 77-55-4(1-phenylcyclopentane-1-carboxylic acid)
• 37828-19-6(1-phenylcyclobutane-1-carboxylic acid)
• 6120-95-2(1-phenylcyclopropane-1-carboxylic acid)
• 90-27-7(2-Phenylbutyric acid)
• 15687-27-1(Ibuprofen)